Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Nutrition and Weight Loss | Endocrinology | Psychiatry/Psychology
 Disease Category: Weight Loss
Location: United States, TX

Trial Information

A 26-week randomised, controlled, open label, multicentre, multinational, treat to target trial investigating the impact of dietary intervention on weight change and the relationship between weight change and baseline body mass index (BMI) in subjects with type 2 diabetes inadequately controlled on oral antidiabetic drugs (OADs) initiating insulin therapy with insulin detemir in combination with metformin

IRB Number: 010-231

This study will be using insulin detemir to compare weight loss effects when randomized to insulin and a dietitian or insulin alone.

Inclusion Criteria:

  • Male or Female 18 or older
  • Diagnosed with Type 2 diabetes for 6 months or longer
  • Are Insulin Naïve
  • On metformin alone or with other orals
  • HbA1c of 7.0 - 9.0

Exclusion Criteria:

  • Using weight loss medications
  • Impaired liver or renal function
  • Cancer within 5 years
  • Edema

Priscilla Hollander, MD
Baylor Research Institute
3600 Gaston Ave, Wadley #656
Dallas, TX 75246
Phone: 214-818-7155

View Map

Research Center Information: Baylor Research Institute

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.